It's 2021, the new year, so of course it's time for someone to suggest a new way to do QC. This time it's the metrologists, and their proposal has a few merits and many more downsides.
We know how to change QC frequency in a data-driven, evidence-based, patient-risk focused way. But we don't seem to be doing it at all.
Taking some recent cobas 8000 data, we assess what goals can be achieved by one of the leading chemistry platforms.
It's October 2020. Time to take a hard look at truth, untruth, and the consequences of pretending there's no difference.
Continuing in our series of Sigma analysis of the leading diagnostic platforms, we turn our attention to the Abbott Alinity, and assess what goals can be achieved by this chemistry instrument.
Probably the feature users will like least about the new Westgard Web is membership. In order to access some articles on the website, you'll need to become a member and login when you visit the website. But membership is free and the benefits of membership outweigh the hassle.